Status:
RECRUITING
Effectiveness of a Blended Care Parenting Intervention for Parents With PTSD (KopOpOuders-PTSD)
Lead Sponsor:
Arkin
Collaborating Sponsors:
Sinai Centrum
Trimbos Institute
Conditions:
Post-traumatic Stress Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
KopOpOuders-PTSD is a new preventive blended care intervention for parents with PTSD. The purpose of this study is to evaluate its effectiveness in improving parenting and preventing child mental heal...
Detailed Description
Rationale: Children of parents with post-traumatic stress disorder (PTSD) are at increased risk of mental health problems, such as depression, anxiety and hyperactivity. They are also more likely than...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Has current DSM-5 diagnosis of PTSD;
- Is receiving PTSD treatment of at least three sessions at one of the following Arkin departments: Sinai Centrum, Jellinek, Punt P, NPI, or Arkin BasisGGZ;
- Has parenting responsibilities for at least one child aged 4-17 (biological or legal relationship not required).
- Exclusion Criteria:
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Has urgent care needs or (imminent) crisis (e.g. current psychosis, substance detoxification, active suicidality);
- Is not in contact with children (e.g. due to out of home placement);
- Is receiving another form of parenting intervention during the participation period;
- Severe psychological problems or intellectual disability (IQ \< 50) are present in children (diagnosis of oppositional-defiant disorder, conduct disorder, psychotic spectrum disorder or personality disorder);
- Inability to participate in the intervention and/or assessments (e.g., because of intellectual disability (IQ \< 75), illiteracy, or insufficient mastery of the Dutch language).
Exclusion
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT05237999
Start Date
May 1 2022
End Date
December 1 2024
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sinai Centrum
Amstelveen, Netherlands, 1186 AM